Kato N - Search Results

1

Prediction of the very early occurrence of HCC right after DAA therapy for HCV infection.

Ooka Y, Miho K, Shuntaro O, Nakamura M, Ogasawara S, Suzuki E, Yasui S, Chiba T, Arai M, Kanda T, Maruyama H, Yokosuka O, Kato N, Mochizuki H, Omata M. Ooka Y, et al. Among authors: kato n. Hepatol Int. 2018 Nov;12(6):523-530. doi: 10.1007/s12072-018-9895-5. Epub 2018 Sep 21. Hepatol Int. 2018. PMID: 30242733

2

Current Options for the Therapy of Chronic Hepatitis B Infection.

Kioko Ono-Nita S, Kato N, Shiratori Y, Omata M. Kioko Ono-Nita S, et al. Among authors: kato n. Curr Infect Dis Rep. 2001 Apr;3(2):137-142. doi: 10.1007/s11908-996-0036-2. Curr Infect Dis Rep. 2001. PMID: 11286654

3

Hepatitis C virus NS4A and NS4B proteins suppress translation in vivo.

Kato J, Kato N, Yoshida H, Ono-Nita SK, Shiratori Y, Omata M. Kato J, et al. Among authors: kato n. J Med Virol. 2002 Feb;66(2):187-99. doi: 10.1002/jmv.2129. J Med Virol. 2002. PMID: 11782927

4

Hepatitis C virus core protein inhibits apoptosis via enhanced Bcl-xL expression.

Otsuka M, Kato N, Taniguchi H, Yoshida H, Goto T, Shiratori Y, Omata M. Otsuka M, et al. Among authors: kato n. Virology. 2002 Apr 25;296(1):84-93. doi: 10.1006/viro.2002.1371. Virology. 2002. PMID: 12036320 Free article.

5

HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis.

Lan KH, Sheu ML, Hwang SJ, Yen SH, Chen SY, Wu JC, Wang YJ, Kato N, Omata M, Chang FY, Lee SD. Lan KH, et al. Among authors: kato n. Oncogene. 2002 Jul 18;21(31):4801-11. doi: 10.1038/sj.onc.1205589. Oncogene. 2002. PMID: 12101418

6

Novel nucleoside analogue MCC-478 (LY582563) is effective against wild-type or lamivudine-resistant hepatitis B virus.

Ono-Nita SK, Kato N, Shiratori Y, Carrilho FJ, Omata M. Ono-Nita SK, et al. Among authors: kato n. Antimicrob Agents Chemother. 2002 Aug;46(8):2602-5. doi: 10.1128/AAC.46.8.2602-2605.2002. Antimicrob Agents Chemother. 2002. PMID: 12121939 Free PMC article.

7

Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway.

Kato J, Kato N, Moriyama M, Goto T, Taniguchi H, Shiratori Y, Omata M. Kato J, et al. Among authors: kato n. J Infect Dis. 2002 Jul 15;186(2):155-63. doi: 10.1086/341467. Epub 2002 Jul 3. J Infect Dis. 2002. PMID: 12134250

8

Weak association between SEN virus viremia and liver disease.

Yoshida H, Kato N, Shiratori Y, Shao R, Wang Y, Shiina S, Omata M. Yoshida H, et al. Among authors: kato n. J Clin Microbiol. 2002 Sep;40(9):3140-5. doi: 10.1128/JCM.40.9.3140-3145.2002. J Clin Microbiol. 2002. PMID: 12202544 Free PMC article.

9

Analysis of the beta-catenin/T cell factor signaling pathway in 36 gastrointestinal and liver cancer cells.

Ikenoue T, Ijichi H, Kato N, Kanai F, Masaki T, Rengifo W, Okamoto M, Matsumura M, Kawabe T, Shiratori Y, Omata M. Ikenoue T, et al. Among authors: kato n. Jpn J Cancer Res. 2002 Nov;93(11):1213-20. doi: 10.1111/j.1349-7006.2002.tb01226.x. Jpn J Cancer Res. 2002. PMID: 12460462 Free PMC article.

10

Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection.

Wang Y, Kato N, Hoshida Y, Yoshida H, Taniguchi H, Goto T, Moriyama M, Otsuka M, Shiina S, Shiratori Y, Ito Y, Omata M. Wang Y, et al. Among authors: kato n. Hepatology. 2003 Jan;37(1):65-71. doi: 10.1053/jhep.2003.50017. Hepatology. 2003. PMID: 12500190

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,941 results

Search Page

Filters